[1]
Uddin, D. et al. 2016. Chemotherapy in combination with Trastuzumab is better than chemotherapy alone in HER2 positive breast cancer patients. Barind Medical College Journal. 2, 2 (Dec. 2016), 15–20. DOI:https://doi.org/10.70818/bmcj.2016.v02.i1.063.